Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Beauty Farm Medical & Health Industry's average EBITDA Per Share Growth Rate was 41.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 24.50% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 10.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Beauty Farm Medical & Health Industry was 24.50% per year. The lowest was 1.70% per year. And the median was 6.35% per year.
Beauty Farm Medical & Health Industry (FRA:XC5) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Beauty Farm Medical & Health Industry 3-Year EBITDA Growth Rate Related Terms
FRA:XC5 vs HCA, THC, EHC: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Beauty Farm Medical & Health Industry's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beauty Farm Medical & Health Industry 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Beauty Farm Medical & Health Industry's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Beauty Farm Medical & Health Industry's 3-Year EBITDA Growth Rate falls into.
Beauty Farm Medical & Health Industry 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 24.50% mean?
Beauty Farm Medical & Health Industry (FRA:XC5) has a 3-Year EBITDA Growth Rate of 24.50% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Beauty Farm Medical & Health Industry and its competitors. This is 286% above median its historical median of 6.35. Over the past decade, Beauty Farm Medical & Health Industry's 3-Year EBITDA Growth Rate has ranged from 1.70 to 24.50. According to the industry distribution chart, Beauty Farm Medical & Health Industry ranks #143 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 27.2%.
Is Beauty Farm Medical & Health Industry's 3-Year EBITDA Growth Rate too high?
Beauty Farm Medical & Health Industry's current 3-Year EBITDA Growth Rate of 24.50% is 286% above median its 10-year median of 6.35. Over the past 10 years, this metric has ranged from a low of 1.70 to a high of 24.50. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.05. Beauty Farm Medical & Health Industry's value of 24.50% is 143.8% above this industry median. Based on the distribution chart, Beauty Farm Medical & Health Industry ranks #143 out of 526 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Beauty Farm Medical & Health Industry has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Beauty Farm Medical & Health Industry's 3-Year EBITDA Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Beauty Farm Medical & Health Industry ranks #143 out of 526 companies for 3-Year EBITDA Growth Rate. This puts Beauty Farm Medical & Health Industry in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.05. Beauty Farm Medical & Health Industry's value of 24.50% is 143.8% above this benchmark. Historically, Beauty Farm Medical & Health Industry's own 3-Year EBITDA Growth Rate has ranged from 1.70 to 24.50 over the past decade. While the company's 10-year median is 6.35 vs. the industry median of 10.05, Beauty Farm Medical & Health Industry has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beauty Farm Medical & Health Industry's current 3-Year EBITDA Growth Rate of 24.50% is 143.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Beauty Farm Medical & Health Industry and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beauty Farm Medical & Health Industry's current 3-Year EBITDA Growth Rate is 24.50%, which is 286% above median its own 10-year median of 6.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beauty Farm Medical & Health Industry stock overvalued right now?
Beauty Farm Medical & Health Industry (FRA:XC5) has a current 3-Year EBITDA Growth Rate of 24.50%. The stock's GF Value™ is €2.68, compared to a current price of €2.08 — trading 22.4% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 24.50%, which is 286% above median its 10-year median of 6.35 and 143.8% above the Healthcare Providers & Services industry median of 10.05. Beauty Farm Medical & Health Industry's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Beauty Farm Medical & Health Industry (FRA:XC5), the current 3-Year EBITDA Growth Rate is 24.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beauty Farm Medical & Health Industry (FRA:XC5) Overvalued in 2026?
Based on GuruFocus' analysis, Beauty Farm Medical & Health Industry stock appears to be undervalued.
The current stock price of €2.08 is trading 22.4% below its estimated GF Value™ of €2.68.
Key valuation signals for FRA:XC5:
3-Year EBITDA Growth Rate: 24.50% (286% above median its 10-year median of 6.35)
GF Value™: €2.68 vs. price of €2.08 (22.4% below fair value)
Industry Position: 143.8% above the Healthcare Providers & Services median (#143 of 526)
No single metric tells the full story. See the FRA:XC5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beauty Farm Medical & Health Industry Inc. provides beauty and wellness services in the People's Republic of China. It offers high-quality beauty and wellness services, aesthetic medical services, and subhealth medical services according to customers' individual needs. The company offers its products and services through brands such as Beauty Farm, Palaispa, Naturade, Cellcare, and Neology.
88GF Score
Get the complete analysis for FRA:XC5
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:XC5 has been successfully added to your 
